Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice

Transplantation

Volumn 78, Issue 8, 2004, Pages 1172-1176

  Lee Pullen, Tracey F ^a   Bennett, Alayne L ^a   Beilharz, Manfred W ^a   Grounds, Miranda D ^a   Sammels, Leanne M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Donor age; Myoblast culture; Myoblast transplantation; Tissue culture

Indexed keywords

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GRAFT SURVIVAL; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TIBIALIS ANTERIOR MUSCLE;

AGING; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELL DIVISION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; FEMALE; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; TIME FACTORS; TISSUE DONORS;

EID: 7044236935     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000137936.75203.B4     Document Type: Article

References (27)

1. Skuk D, Tremblay JP. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 2003; 24(4-6): 285.
2. Partridge T. Myoblast transplantation. Neuromuscul Disord 2002; 12: S3.
3. Smythe GM, Hodgetts SI, Grounds MD. Immunobiology and the future of myoblast transfer therapy. Mol Ther 2000; 1(4): 304.
4. Tremblay J, Guerette B. Myoblast transplantation: a brief review of the problems and some solutions. Basic Appl Myol 1997; 7: 221.
5. Fan Y, Maley M, Beilharz M, et al. Rapid death of donor myoblasts after intramuscular injection in myoblast transfer therapy. Muscle Nerve 1996; 19: 853.
6. Hodgetts SI, Beilharz MW, Scalzo AA, et al. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 2000; 9(4): 489.
7. Beauchamp JR, Morgan JE, Pagel CN, et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144(6): 1113.
8. Sammels LM, Bosio E, Fragall CT, et al. Innate inflammatory cells are not responsible for early death of donor myoblasts following myoblast transfer therapy. Transplantation 2004; 77(12): 1790.
9. Qu Z, Balkir L, van Deutekom JC, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998; 142(5): 1257.
10. Qu-Petersen Z, Deasy B, Jankowski R, et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002; 157(5): 851.
11. Skuk D, Caron NJ, Goulet M, et al. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 2003; 62(9): 951.
12. Beauchamp JR, Heslop L, Yu DS, et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000; 151(6): 1221.
13. Beilharz MW, Lareu RR, Garrett KL, et al. Quantitation of muscle precursor cell activity in skeletal muscle by northern analysis of MyoD and myogenin expression: application to dystrophic (mdx) mouse muscle. Mol Cell Neurosci 1992; 3(4): 326.
14. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration [ed 1]. London, Chapman & Hall 1993.
15. Partridge TA. Tissue culture of skeletal muscle. In: Pollard JW, Walker JM, eds. Methods in Molecular Biology. Humana Press, 1997: 131.
16. Grounds MD. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann N Y Acad Sci 1998; 854: 78.
17. Decary S, Mouly V, Ben Hamida C, et al. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell mediated gene therapy. Hum Gene Ther 1997; 8(12): 1429.
18. Renault V, Piron-Hamelin G, Forestier C, et al. Skeletal muscle regeneration and the mitotic clock. Exp Gerontol 2000; 35(6-7): 711.
19. Skuk D, Goulet M, Roy B, et al. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 2000; 59(3): 197.
20. Zammit PS, Heslop L, Hudon V, et al. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 2002; 281(1): 39.
21. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000; 150(5): 1085.
22. Deasy BM, Qu-Peterson Z, Greenberger JS, et al. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 2002; 20(1): 50.
23. Mueller GM, O'Day T, Watchko JF, et al. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Hum Gene Ther 2002; 13(9): 1081.
24. Jankowski RJ, Haluszczak C, Trucco M, et al. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 2001; 12(6): 619.
25. Asakura A, Seale P, Girgis-Gabardo A, et al. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002; 159(1): 123.
26. Byrne P, Huang W, Wallace VM, et al. Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR. Biotechniques 2002; 32(2): 279.
27. Partridge TA, Morgan JE, Coulton GR, et al. Conversion of mdx myofibres from dystrophin-negative to dystrophin-positive by injection of normal myoblasts. Nature 1989; 337: 176.